# US 2023/0390585 A1 · Methods for optimizing treatment time and plan quality for radiotherapy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0390585 A1
- Document ID: US20230390585A1
- Status: Published application
- Kind: A1
- Application number: 18/454,663
- Filed: 2023-08-23
- Published: 2023-12-07
- Earliest claimed: 2021-02-24
- Assignees: RefleXion Medical, Inc.
- Applicants: RefleXion Medical, Inc.
- Inventors: Aleksei PRIVALIKHIN; Yevgen VORONENKO; Peter Demetri OLCOTT
- Web page: https://patentgrep.com/patent/US20230390585A1

## CPC

- A61N 5/1048: {Monitoring, verifying, controlling systems and methods}
- A61N 5/103: {Treatment planning systems}
- A61N 5/1031: {using a specific method of dose optimization}
- G16H 20/40: relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/50: for simulation or modelling of medical disorders
- A61N 2005/1074: {Details of the control system, e.g. user interfaces}
- G16H 40/60: for the operation of medical equipment or devices
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Described herein is a graphical user interface that receives a user-specified treatment time value and displays the resultant dose distributions to a target region and/or organs-at-risk (OARs). The dose distributions are depicted as dose volume histograms (DVHs). The user-specified treatment time value may be adjusted as desired and the DVHs for the target region and/or OARs may be correspondingly updated. In some variations, the graphical user interface may comprise bounded DVHs for the target region and/or OARs, where bounds of the DVH represent the range of dose variability between a short treatment time (e.g., Tmin) and a long treatment time (e.g., Tmax). In some variations, the graphical user interface includes a command button that triggers fluence map optimization using the user-specified treatment time.

## Claims

### Claim 1

A graphical user interface for radiotherapy planning, the graphical user interface comprising:
a bounded dose volume histogram (bDVH) for a target region comprising a lower bound DVH and an upper bound DVH that represent a range of radiation dose values to the target region over a range of treatment delivery times;
a treatment time selector configured to receive user input that specifies a treatment delivery time within the range of treatment times; and
a variable dose volume histogram (DVH) for the target region that represents a radiation dose to the target region that corresponds to the specified treatment delivery time.

### Claim 2 (depends on 1)

The graphical user interface of claim 1, wherein the lower bound DVH corresponds to a lower-limit treatment delivery time value and the upper bound DVH corresponds to an upper-limit treatment delivery time value.

### Claim 3 (depends on 2)

The graphical user interface of claim 2, wherein the lower-limit treatment delivery time value is a minimum treatment delivery time value, and the upper-limit treatment delivery time value is a maximum treatment delivery time value.

### Claim 4 (depends on 1)

The graphical user interface of claim 1, wherein the bDVH for the target region further comprises shading between the upper bound DVH curve and the lower bound DVH curve.

### Claim 5 (depends on 1)

The graphical user interface of claim 1, wherein the variable DVH curve for the target region changes between the upper bound DVH curve and the lower bound DVH curve according to the user input to the treatment time selector.

### Claim 6 (depends on 1)

The graphical user interface of claim 1, wherein the treatment time selector is a graphical slider that is movable between a first limit that corresponds to a low-threshold treatment delivery time value and a second limit that corresponds to a high-threshold treatment delivery time value, and wherein moving the slider to a position between the first and second limits corresponds to selecting the treatment delivery time.

### Claim 7 (depends on 1)

The graphical user interface of claim 1, wherein the treatment time selector is a graphical dial that is rotatable between a first limit corresponding to a low-threshold treatment delivery time and a second limit corresponding to a high-threshold treatment delivery time, and wherein setting the dial to a position between the first and second limits corresponds to selecting the treatment delivery time.

### Claim 8 (depends on 1)

The graphical user interface of claim 1, further comprising a second bDVH for a volume of interest (VOI) comprising a second lower bound DVH curve and a second upper bound DVH curve that represent a range of radiation dose values to the VOI over the range of treatment delivery times, and a second variable DVH curve for the VOI that represents a radiation dose to the VOI that corresponds to the specified treatment delivery time.

### Claim 9 (depends on 8)

The graphical user interface of claim 8, wherein the second bDVH for the VOI further comprises shading between the upper bound DVH curve and the lower bound DVH curve.

### Claim 10 (depends on 8)

The graphical user interface of claim 8, wherein the second variable DVH curve for the VOI changes between the upper bound DVH curve and the lower bound DVH curve of the second bDVH for the VOI according to the user input to the treatment time selector.

### Claim 11 (depends on 8)

The graphical user interface of claim 8, wherein the VOI comprises a heart.

### Claim 12 (depends on 8)

The graphical user interface of claim 8, wherein the VOI comprises a spinal cord.

### Claim 13 (depends on 8)

The graphical user interface of claim 8, wherein the VOI comprises an esophagus.

### Claim 14 (depends on 8)

The graphical user interface of claim 8, wherein the VOI comprises an organ-at-risk (OAR).

### Claim 15 (depends on 8)

The graphical user interface of claim 8, further comprising a third bDVH for a second VOI comprising a third lower bound DVH curve and a third upper bound DVH curve that represent a range of radiation dose values to the second VOI over the range of treatment delivery times, and a third variable DVH curve for the second VOI that represents a radiation dose to the second VOI that corresponds to the specified treatment delivery time.

### Claim 16 (depends on 15)

The graphical user interface of claim 15, further comprising a DVH-viewer selection menu that includes a graphical selection toggle for each of the first, second and third bDVHs, wherein a user-selection of a first toggle state displays the corresponding bDVH and a second toggle state hides the corresponding bDVH.

### Claim 17 (depends on 16)

The graphical user interface of claim 16, wherein the first, second and third bDVHs are each depicted with different colors.

### Claim 18 (depends on 1)

The graphical user interface of claim 1, further comprising a first text field that indicates a mean dose to the target region and a second text field that indicates a maximum dose to the target region for the specified treatment delivery time.

### Claim 19 (depends on 1)

The graphical user interface of claim 1, further comprising a graphical indicator of the treatment delivery time specified by the treatment time selector.

### Claim 20 (depends on 1)

The graphical user interface of claim 1, further comprising a command button that is triggers treatment plan optimization with the treatment delivery time specified by the treatment time selector.

### Claim 21 (depends on 3)

The graphical user interface of claim 3, wherein the minimum treatment delivery time value is determined by
generating a fluence map comprising a set of beamlet values by iteratively adjusting the beamlet values based on a cost function comprising a treatment time penalty function such that the fluence map delivers a prescribed dose to the target region and changes of a cost function value between iterations of the beamlet values is less than a selected threshold, and
calculating an amount of time to deliver the generated fluence map.

### Claim 22 (depends on 3)

The graphical user interface of claim 3, wherein the maximum treatment delivery time value is determined by
generating a fluence map comprising a set of beamlet values by iteratively adjusting the beamlet values based on a cost function comprising an organ-at-risk (OAR) dose penalty function such that the fluence map delivers a prescribed dose to the target region and changes of a mean dose to the OAR between iterations of the beamlet values is less than a selected threshold, and
calculating an amount of time to deliver the generated fluence map.

### Claim 23

A graphical user interface for radiotherapy planning, the graphical user interface comprising:
a treatment time axis;
a lower limit indicator on the treatment time axis, wherein the lower-limit indicator is at a minimum treatment time for delivering a prescribed dose to a target region;
an upper limit indicator on the treatment time axis, wherein the upper-limit indicator is at a maximum treatment time for delivering the prescribed dose to the target region; and
a treatment time indicator on the treatment time axis between the lower limit indicator and the upper limit indicator, wherein the treatment time indicator is at an initial treatment time for delivering the prescribed dose to the target region.

### Claim 24 (depends on 23)

The graphical user interface of claim 23, wherein the initial treatment time is calculated by
generating a fluence map comprising a set of radiation beamlet weights by iteratively adjusting the beamlet weights based on a cost function comprising an OAR penalty function such that the fluence map delivers the prescribed dose to the target region and changes of a cost function value between iterations of the beamlet weights is less than a selected threshold; and
calculating an amount of time to deliver the generated fluence map.

### Claim 25 (depends on 24)

The graphical user interface of claim 24, wherein the minimum treatment time is determined by
generating a fluence map comprising a set of beamlet values by iteratively adjusting the beamlet values based on a cost function comprising a treatment time penalty function such that the fluence map delivers the prescribed dose to the target region and changes of a cost function value between iterations of the beamlet values is less than a selected threshold, and
calculating an amount of time it takes to deliver the generated fluence map.

### Claim 26 (depends on 24)

The graphical user interface of claim 24, wherein the maximum treatment time is determined by
generating a fluence map comprising a set of beamlet values by iteratively adjusting the beamlet values based on a cost function comprising an organ-at-risk (OAR) dose penalty function such that the fluence map delivers a prescribed dose to the target region and changes of a mean dose to the OAR between iterations of the beamlet values is less than a selected threshold, and
calculating an amount of time to deliver the generated fluence map.

### Claim 27

A method for generating a graphical user interface (GUI) for radiotherapy planning, the method comprising:
generating a first fluence map that delivers a prescribed dose to a target region using a cost function having a plurality of penalty functions including a treatment time penalty function that is more heavily weighted than the other penalty functions;
calculating an amount of time Tmin to deliver the first fluence map;
generating a second fluence map that delivers a prescribed dose to a target region and optimizes a dose to a radiation-avoidance region;
calculating an amount of time Tmax to deliver the second fluence map;
generating a plurality of fluence maps that have treatment delivery times between Tmin and Tmax;
generating a bounded dose volume histogram (bDVH) for the target region that represents a dose variability across the first fluence map, the second fluence map, and the generated plurality of fluence maps;
generating a GUI that comprises the bDVH, a treatment time selector configured to specify a treatment delivery time between Tmin and Tmax, and a variable DVH curve for the target region that represents a dose to the target region that corresponds to a variable fluence map that has a treatment delivery time that approximates the specified treatment delivery time; and
outputting the GUI to a display device.

### Claim 28 (depends on 27)

The method of claim 27, further comprising generating a bDVH for the radiation-avoidance region that represents a dose variability between the first fluence map and the second fluence map.

### Claim 29 (depends on 28)

The method of claim 28, further comprising generating a variable DVH curve for the radiation-avoidance region that represents a dose to the radiation-avoidance region that corresponds to the variable fluence map.

### Claim 30 (depends on 29)

The method of claim 29, further comprising updating the variable DVH for the radiation-avoidance region in response to selections of treatment delivery times as specified by the treatment time selector.

### Claim 31 (depends on 27)

The method of claim 27, further comprising updating the variable DVH for the target region in response to selections of treatment delivery times as specified by the treatment time selector.

### Claim 32 (depends on 30)

The method of claim 30, further comprising generating a final fluence map based on a final selection of a treatment delivery time by the treatment time selector.

### Claim 33 (depends on 27)

The method of claim 27, wherein the first fluence map comprises a first set of beamlet values, and wherein generating the first fluence map comprises iteratively adjusting the first set of beamlet values based on the cost function such that the first fluence map delivers a prescribed dose to the target region.

### Claim 34 (depends on 33)

The method of claim 33, wherein the second fluence map comprises a second set of beamlet values, and wherein generating the second fluence map comprises defining a second cost function comprising a radiation-avoidance region penalty function and no treatment time penalty function, and optimizing the dose to the radiation-avoidance region comprises iteratively adjusting the second set of beamlet values based on the second cost function such that the second fluence map delivers a prescribed dose to the target region and changes of a mean dose to the radiation-avoidance region between iterations of the beamlet values is less than a selected threshold.

### Claim 35 (depends on 27)

The method of claim 27, further comprising generating additional DVHs corresponding to the additional fluence maps for the target region.

### Claim 36 (depends on 35)

The method of claim 35, further comprising generating additional DVHs corresponding to the additional fluence maps for the radiation-avoidance region.

### Claim 37 (depends on 27)

The method of claim 27, wherein generating additional fluence maps comprises
selecting a treatment delivery time Tselected that is between Tmin and
generating an intermediate fluence map comprising a set of beamlet values by combining the first fluence map and the second fluence map,
adjusting the treatment time penalty function of the cost function according to the selected treatment delivery time Tselected, and
generating an additional fluence map for the selected treatment delivery time Tselected by iteratively adjusting the beamlet values of the intermediate fluence map based on the adjusted cost function such that the target region receives the prescribed dose and changes of the cost function value between iterations of the beamlet values is less than a selected threshold.

### Claim 38 (depends on 36)

The method of claim 36, wherein combining the first fluence map and the second fluence map comprises generating an approximation of a Pareto optimal fluence map.

### Claim 39 (depends on 37)

The method of claim 37, wherein the approximation of a Pareto optimal fluence map comprises a convex combination of the first fluence map and the second fluence map.

### Claim 40 (depends on 36)

The method of claim 36, wherein adjusting the treatment time penalty function comprises changing the treatment time penalty function from w·Test to w·|Test−Tselected|1+, where w is a weight of the treatment time penalty function, and Test is the treatment time for an iteration of a fluence map.

### Claim 41 (depends on 36)

The method of claim 36, wherein the selected treatment delivery time is halfway between Tmin and Tmax.

### Claim 42 (depends on 27)

The method of claim 27, wherein generating the plurality of fluence maps comprises calculating a plan quality metric value for each fluence map and defining sub-ranges of treatment delivery times between Tmin and Tmax for treatment delivery times that correspond to fluence maps that have plan quality metric values that differ from each other by more than a specified margin.

### Claim 43 (depends on 42)

The method of claim 42, wherein generating the plurality of fluence maps that have treatment delivery times between Tmin and Tmax comprises
defining, for each treatment delivery time, a cost function that has a treatment time penalty that includes a treatment time threshold that corresponds with the respective treatment time, and
iteratively adjusting fluence map beamlet values based on the defined cost function such that the target region receives the prescribed dose and changes of the cost function value between iterations is less than a selected threshold.

### Claim 44 (depends on 43)

The method of claim 43, wherein generating the plurality of fluence maps further comprises repeatedly defining sub-ranges of treatment delivery times, selecting treatment times within the sub-ranges, generating fluence maps for the selected treatment times, and calculating the plan quality metric value for the generated fluence maps.

### Claim 45 (depends on 42)

The method of claim 42, wherein the plan quality metric value is calculated from a mean dose to the radiation-avoidance region.

### Claim 46 (depends on 42)

The method of claim 42, wherein the plan quality metric value is calculated from a cost function value for the fluence map.

### Claim 47 (depends on 36)

The method of claim 36, further comprising updating the variable DVH curve for the target region in response to an updated treatment delivery time specified by the treatment time selector.

### Claim 48 (depends on 47)

The method of claim 47, wherein updating the variable DVH comprises interpolating between DVHs that correspond to fluence maps that have treatment delivery times that bound the updated treatment delivery time.

### Claim 49 (depends on 47)

The method of claim 47, wherein updating the variable DVH comprises interpolating between fluence maps that have treatment delivery times that bound the updated treatment delivery time to generate an interpolated fluence map, and generating the updated variable DVH from the interpolated fluence map.

### Claim 50 (depends on 47)

The method of claim 47, further comprising calculating mean doses to the target region and the radiation-avoidance region and calculating maximum doses to the target region and the radiation-avoidance region, and
wherein the GUI comprises a text field that displays the mean and maximum doses for the target region and the radiation-avoidance region, and
wherein updating the variable DVH curve further comprises updating the mean and maximum doses for the target region and the radiation-avoidance region.
